2024, Vol 14, No. 3

Editor-in-Chief

Prof. Khosro Adibkia

Editorial

1. Bioimpacts of nanoparticle size: why it matters?

Jaleh Barar*

Bioimpacts. 2015;5(3): 113-115. doi: 10.15171/bi.2015.23

PMCID: PMC4597157 PMID: 26457247 Scopus ID: 84944413654

Article

PDF

XML

Cited By:

Review

2. Impacts of Blood-Brain Barrier in Drug Delivery and Targeting of Brain Tumors

Yadollah Omidi* , Jaleh Barar

Bioimpacts. 2012;2(1): 5-22. doi: 10.5681/bi.2012.002

PMCID: PMC3648919 PMID: 23678437 Scopus ID: 84876731279

Article

PDF

XML

Cited By:

Review

3. Advanced drug delivery and targeting technologies for the ocular diseases

Jaleh Barar , Ayuob Aghanejad, Marziyeh Fathi, Yadollah Omidi*

Bioimpacts. 2016;6(1): 49-67. doi: 10.15171/bi.2016.07

PMCID: PMC4916551 PMID: 27340624 Scopus ID: 84977080654

Article

PDF

Full Text

XML

Cited By:

105

Review

4. Blood-brain barrier transport machineries and targeted therapy of brain diseases

Jaleh Barar , Mohammad A. Rafi, Mohammad M. Pourseif, Yadollah Omidi*

Bioimpacts. 2016;6(4): 225-248. doi: 10.15171/bi.2016.30

PMCID: PMC5326671 PMID: 28265539 Scopus ID: 85013096202

Article

PDF

Full Text

XML

Cited By:

160

147

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons